chr3-57237538-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_012096.3(APPL1):āc.200A>Gā(p.Glu67Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000383 in 1,598,782 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0019 ( 0 hom., cov: 33)
Exomes š: 0.00022 ( 1 hom. )
Consequence
APPL1
NM_012096.3 missense
NM_012096.3 missense
Scores
2
4
12
Clinical Significance
Conservation
PhyloP100: 4.72
Genes affected
APPL1 (HGNC:24035): (adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1) The protein encoded by this gene has been shown to be involved in the regulation of cell proliferation, and in the crosstalk between the adiponectin signalling and insulin signalling pathways. The encoded protein binds many other proteins, including RAB5A, DCC, AKT2, PIK3CA, adiponectin receptors, and proteins of the NuRD/MeCP1 complex. This protein is found associated with endosomal membranes, but can be released by EGF and translocated to the nucleus. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.008472085).
BP6
Variant 3-57237538-A-G is Benign according to our data. Variant chr3-57237538-A-G is described in ClinVar as [Benign]. Clinvar id is 1336573.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 296 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
APPL1 | NM_012096.3 | c.200A>G | p.Glu67Gly | missense_variant | 3/22 | ENST00000288266.8 | |
APPL1 | XM_011533583.4 | c.149A>G | p.Glu50Gly | missense_variant | 4/23 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
APPL1 | ENST00000288266.8 | c.200A>G | p.Glu67Gly | missense_variant | 3/22 | 1 | NM_012096.3 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00194 AC: 296AN: 152204Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
296
AN:
152204
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000541 AC: 128AN: 236630Hom.: 0 AF XY: 0.000336 AC XY: 43AN XY: 128076
GnomAD3 exomes
AF:
AC:
128
AN:
236630
Hom.:
AF XY:
AC XY:
43
AN XY:
128076
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000219 AC: 317AN: 1446460Hom.: 1 Cov.: 28 AF XY: 0.000170 AC XY: 122AN XY: 718950
GnomAD4 exome
AF:
AC:
317
AN:
1446460
Hom.:
Cov.:
28
AF XY:
AC XY:
122
AN XY:
718950
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00194 AC: 296AN: 152322Hom.: 0 Cov.: 33 AF XY: 0.00183 AC XY: 136AN XY: 74476
GnomAD4 genome
AF:
AC:
296
AN:
152322
Hom.:
Cov.:
33
AF XY:
AC XY:
136
AN XY:
74476
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
26
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
90
Asia WGS
AF:
AC:
2
AN:
3462
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Oct 14, 2019 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 10, 2024 | - - |
APPL1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 06, 2020 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
T;T;T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
M;.;.
MutationTaster
Benign
D
PrimateAI
Pathogenic
T
PROVEAN
Benign
N;D;D
REVEL
Benign
Sift
Benign
T;T;T
Sift4G
Uncertain
T;D;D
Polyphen
B;.;P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at